ID
45757
Descrição
Principal Investigator: Daphne W. Bell, PhD, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA MeSH: Endometrial Neoplasms,Carcinosarcoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001152 The purpose of this study was to identify somatic (tumor-specific) mutations in endometrial carcinosarcoma tumor exomes. The dataset was generated at the NIH Intramural Sequencing Center (NISC) and NHGRI by next generation sequencing the exomes of 14 de-identified primary tumor DNAs and matched non-tumor DNAs.
Link
Palavras-chave
Versões (1)
- 14/06/2023 14/06/2023 - Chiara Middel
Titular dos direitos
Daphne W. Bell, PhD, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
Transferido a
14 de junho de 2023
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs001152 Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas
Subject ID and sex of participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with endometrial carcinosarcomas tumors and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Subject ID and sex of participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor or metastasis, primary tumor location, and name of the center which conducted sequencing of samples obtained from participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
Similar models
Subject ID and sex of participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with endometrial carcinosarcomas tumors and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Subject ID and sex of participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor or metastasis, primary tumor location, and name of the center which conducted sequencing of samples obtained from participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
Sem comentários